Epitranscriptomic regulation of antimony resistance in Leishmania via m6A RNA modification

Leishmaniasis is a devastating disease caused by microscopic parasites that live inside sand flies and infect humans, leading to severe skin sores or fatal damage to internal organs. For decades, doctors have fought these parasites with drugs based on antimony, a heavy metal element. However, the parasites have learned to survive, evolving resistance that renders the treatment useless in many parts of the world. For a long time, scientists believed this survival was due to slow, permanent changes in the parasite's genetic code, similar to how a species might slowly evolve over thousands of years. But these genetic changes take time to happen, and parasites often adapt to drugs much faster than that. This speed suggests there is a hidden, faster layer of control that the parasites use to survive before their DNA even has a chance to change.

A team of researchers has now uncovered this hidden layer in the parasite Leishmania infantum. They discovered that the parasite uses chemical tags attached to its RNA—the molecule that carries instructions from DNA to build proteins—to rapidly switch its behavior on and off. Specifically, they found a modification called N6-methyladenosine, which acts like a molecular switch on the RNA. When the parasite senses the antimony drug, it dramatically changes the pattern of these tags. This allows the parasite to quickly turn down the genes that let the drug enter its body and turn up the genes that pump the drug out, all without altering its underlying genetic blueprint. This process is reversible; if the drug is removed, the parasite resets its tags and becomes sensitive to the medicine again, only to change them once more if the drug returns.

The researchers began by growing Leishmania infantum parasites in the laboratory. They took a strain that was sensitive to the drug and slowly exposed it to increasing amounts of antimony. As the drug pressure increased, the parasites became resistant, surviving concentrations that would have killed the original strain. The team then measured the total amount of these chemical RNA tags in the sensitive parasites, the resistant ones, and a third group that had been grown without the drug for many generations to see if they could become sensitive again. They found a clear pattern: the more drug the parasites faced, the fewer chemical tags they had on their RNA. When the drug was removed, the tags returned to normal levels. When the drug was reintroduced, the tags disappeared again. This showed that the parasite was not just passively surviving but actively rewriting its chemical instructions in response to the threat.

To see exactly which instructions were being rewritten, the scientists used a powerful technology called direct RNA sequencing. This method allows researchers to read the RNA molecules directly, detecting the chemical tags as they pass through a tiny pore. They analyzed the RNA from the sensitive parasites, the highly resistant ones, and the ones that had been resensitized. They found thousands of specific locations on the RNA where these tags were present. In the resistant parasites, the total number of tags dropped significantly compared to the sensitive ones. More importantly, the tags were not just disappearing randomly; they were moving to specific spots on the RNA of genes known to control drug resistance.

The study focused on two key genes that act as the parasite's main defense system. One gene, called AQP1, acts like a door that lets the drug enter the cell. In the resistant parasites, this gene had fewer chemical tags, and the cell produced less of the protein it codes for, effectively closing the door to the drug. The other gene, called MRPA, acts like a pump that pushes the drug out of the cell. In the resistant parasites, this gene gained a new chemical tag in a specific spot, and the cell produced much more of this pump, aggressively expelling the drug. The researchers found that for these critical resistance genes, the presence of the chemical tag was directly linked to how much of the protein was made. When the tag was there, the gene was active; when it was gone, the gene was quiet.

This connection was not just a coincidence. The team compared the chemical tags and the gene activity for thousands of genes at once and found a strong, positive relationship. When a gene gained a tag, it tended to become more active. When it lost a tag, it tended to become less active. This relationship was even stronger for the specific genes involved in fighting the drug than for the rest of the parasite's genome. The researchers also noted that the parasites did not change the type of chemical tag they used; they simply changed where the tags were placed and how many there were. This suggests the parasite has a sophisticated system to quickly reprogram its behavior by rearranging these chemical markers.

The ability to reverse this process is perhaps the most striking finding. When the resistant parasites were grown for many generations without any drug, they lost their resistance and became sensitive again. During this time, their chemical tags returned to the pattern seen in the original sensitive parasites. If the drug was added back, the parasites quickly lost the tags again and became resistant. This behavior indicates that the parasite has an "epitranscriptomic memory," a way of remembering its environment and adjusting its survival strategy without waiting for slow genetic mutations to occur.

These findings challenge the old view that drug resistance in parasites is solely a result of permanent genetic changes. Instead, the study shows that parasites can use these chemical RNA tags as a rapid, flexible first line of defense. This allows them to adapt almost immediately when a drug is introduced, buying them time until more permanent genetic changes can take hold. The researchers suggest that understanding this mechanism could lead to new treatments. If scientists can find a way to stop the parasite from changing these chemical tags, they might be able to prevent the parasite from adapting to the drug in the first place, or even reverse the resistance in parasites that have already become immune. The study highlights that the battle against infectious disease is not just fought against the parasite's DNA, but also against the dynamic chemical instructions that tell the DNA how to behave.